...
首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting.
【24h】

Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting.

机译:肝素化的体外循环和低系统抗凝:近6000例接受冠状动脉旁路移植术的患者的分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: Heparin coating of cardiopulmonary bypass circuits reduces the inflammatory response and increases the thromboresistance during extracorporeal circulation. These properties enables a lower systemic heparin dose, which has been shown to reduce the need for blood transfusions. Experience with this technique accumulated over 11 years has been analyzed. METHODS: All patients underwent on-pump coronary artery bypass grafting with heparin-coated circuits. Apart from some patients receiving a high intraoperative dose of aprotinin, the systemic heparin dose was reduced, with a lower level of an activated clotting time of 250 seconds during extracorporeal circulation. The overall strategy aimed at a fast-track regimen, with early extubation, minimal use of blood transfusions, and rapid postoperative recovery. RESULTS: Altogether, 5954 patients were included; 1131 (19.0%) were female (median age, 70 years), and 4823 were male (median age, 65 years). The median additive EuroSCORE was 3 (range, 0-14; mean 3.5 +/- 2.5). No significant signs of clotting were seen in any part of the extracorporeal circuit. Bank blood products were given to 427 (7.2%) patients. Median extubation time was 1.7 hours. The stroke rate was 1.0%, transient neurologic deficits occurred in 0.7%, and perioperative myocardial infarction occurred in 1.2%. On the fifth day, 88.1% of the patients were physically rehabilitated and ready for discharge. Thirty-day mortality was 0.9% (54 patients). CONCLUSIONS: The experience with this patient cohort including mostly low- to medium-risk patients with a relatively short cardiopulmonary bypass time indicates that coronary artery bypass grafting performed with heparin-coated circuits and reduced level of systemic heparinization is safe and results in a very satisfactory clinical course. No signs of clotting or other technical incidents were recorded.
机译:目的:体外循环中肝素涂层可减少炎症反应并增加血栓抵抗力。这些特性可降低全身性肝素剂量,已显示可减少输血需求。分析了使用这种技术11年以来积累的经验。方法:所有患者均进行了泵上冠状动脉旁路移植术,肝素涂层回路。除了一些术中接受高剂量抑肽酶的患者外,全身肝素剂量减少了,体外循环期间的激活凝血时间降低了250秒。总体策略旨在采用快速治疗方案,尽早拔管,尽量少使用输血和术后迅速恢复。结果:共纳入5954例患者。女性(中位年龄为70岁)为1131(19.0%),男性(中位年龄为65岁)为4823。添加剂EuroSCORE的中位数为3(范围为0-14;平均值为3.5 +/- 2.5)。在体外回路的任何部分均未见明显的凝血迹象。向427名(7.2%)患者提供了银行血液制品。拔管时间中位数为1.7小时。卒中率为1.0%,短暂性神经功能缺损为0.7%,围手术期心肌梗塞为1.2%。第五天,有88.1%的患者身体康复并准备出院。 30天死亡率为0.9%(54例患者)。结论:该患者队列的经验包括大多数低至中度风险患者,其心肺旁路手术时间相对较短,这表明使用肝素涂层回路进行冠状动脉旁路移植术并降低了肝素化水平是安全的,并取得了令人满意的结果临床过程。没有记录到凝块或其他技术事件的迹象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号